ReGen Biologics, Inc. provides decision support information systems and consulting services to the health care industry. It offers outcomes-based products and services. The company's technology focuses on guided tissue generation. ReGen Biologics was founded by Shu-Tung Li on September 1, 1987 and is headquartered in Hackensack, NJ.
Sector:
Health Services
Industry:
Servicestothe Health Industry
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Regen Biologics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Regen Biologics, Inc. market cap is $250,144.00.